Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    Global Call for Collaborators – Pfizer Migraine Research
    Release Date:
    Review Process: Pfizer Internal
    Research Internal Medicine All
    Improving care in headache medicine and the management of migraine
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Israel
    The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology China
    Elevating IBD Management Standards Through Targeted Education
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Turkey
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    New Mechanisms and Emerging Treatment Options in Metastatic Breast Cancer
    Release Date:
    Partner: Arvinas
    Review Process: Pfizer Internal
    Education Oncology All
    Addressing Knowledge Gaps in Aplastic Anemia
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Gene and Gene-modified Cell Therapies Medical Education
    Release Date:
    Partner: American Society of Gene + Cell Therapy
    Review Process: Expert Review Panel
    Education Rare Disease All
    Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Internal Medicine Japan
    Efforts to Improve Quality of Migraine Medical Care
    Release Date:
    Partner: The Japanese Headache Society
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Education Internal Medicine Japan
    Pathological diagnosis and Immunohistochemistry biomarker assessments of Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Ghana
    Evolving Treatment Options in First-line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Promoting Understanding of COVID-19 and Vaccination and Improving Communication Skills for Healthcare Professionals
    Release Date:
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    American Headache Society Quality Improvement Competitive Grant Program
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
    Boosting Oncology Opportunities for Support programs and Treatment, (BOOST), An Oncology Quality Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    Understanding the Mechanisms and Formulating the Optimal Management of Hematological Toxicity of PARPi
    Release Date:
    Partner: National Comprehensive Cancer Network
    Review Process: Expert Review Panel
    Research Oncology USA
    Improving Care for Patients with Recurrent/Metastatic (R/M) Cervical Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA